(1alpha,3beta,5alpha, 5alphabeta,6alpha,9alpha,9alphabeta)-5a,6,9,9a-tetrahhydro-N-(triphenylphosphoranylidene)-6,9-methano-1,5-nitrilo-1H,3H-1,3,5,2,-benzotrithiadiazepin-3-amine
Compound with spectra: 1 NMR
| SpectraBase Compound ID | CX3bn5676Vb |
|---|---|
| InChI | InChI=1S/C26H23N4PS3/c1-4-10-19(11-5-1)31(20-12-6-2-7-13-20,21-14-8-3-9-15-21)27-34-29-32-24-22-16-17-26(22)18-23(26)25(24)33(28-32)30-34/h1-17,22-25H,18H2/t22?,23?,24-,25-,26?,32?,33?,34?/m0/s1 |
| InChIKey | BGYFALMNOBOZCP-YXSPISSLSA-N |
| Mol Weight | 518.65 g/mol |
| Molecular Formula | C26H23N4PS3 |
| Exact Mass | 518.082247 g/mol |
| Enantiomer InChIKey | BGYFALMNOBOZCP-YEZBGWDASA-N |
| Copyright | Copyright © 2009-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3aR,5aR,7aR,7bS)-2,2-dimethyl-6,6-diphenyl-3a,5a,7a,7b-tetrahydrocyclobuta[g][1,3]benzodioxol-7-one
Asparagine, N-(2-acetamido-2-deoxy-.beta.-D-glucopyranosyl)-N2-(trifluoroacetyl)-, ethyl ester, 3',4',6'-triacetate, L-
pyrano[2,3-c]pyrazole-5-carbonitrile, 6-amino-4-(2-fluorophenyl)-2,4-dihydro-3-propyl-
6-Phenyl-5a,6,7,8,9,10,11,11a-octahydrobenzo[b]carbazole isomer
2-OXABICYCLO[4.2.0]OCT-4-EN-3-ONE, REL-(1R,6S,7S,8S)-5-METHOXY-7-(3-METHYLPHENYL)-8-(4-METHOXY-2-OXO-2H-PYRAN-6-YL)-1-[(E)-2-(3-METHYL
thieno[2,3-b]pyridine-2-carboxamide, 4,5,6,7-tetrahydro-3-methyl-6-oxo-N-phenyl-4-[3-(trifluoromethyl)phenyl]-
6-Amino-4-(2-chlorophenyl)-3-propyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
(+)-(1S,5AS,7AR,7BR)-7-HYDROXY-1-[(4-NITROBENZOYL)-OXY]-6-OXAOCTAHYDRO-2H-CYCLOPENTA-[GH]-PYRROLIZIN-2-ONE
Quinazolin-4(3H)-one, 1,2-dihydro-3-benzyl-2-(2,4,5-trimethoxyphenyl)-
phenyl-(2,2,4-trimethyl-1-benzo[h]quinolinyl)methanone
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.